SIEVE logo

Diverse participation in clinical research- a scientific necessity

One of the latest medical advancements making waves is Eisai and Biogen developed Lecanemab. It was recently presented at the Clinical Trials on Alzheimer’s Disease conference in San Francisco.  There is no debate over Lecanemab’s dramatic effect on amyloid. When measured by PET scan, patients taking the medicine saw their amyloid levels decline by about […]